These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19493078)

  • 1. When scientists deceive: applying the federal regulations.
    O'Neil CC; Miller FG
    J Law Med Ethics; 2009; 37(2):344-50. PubMed ID: 19493078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United States regulatory requirements for research involving human subjects.
    J Biolaw Bus; 1998; 1(2):39-53. PubMed ID: 12739542
    [No Abstract]   [Full Text] [Related]  

  • 3. Deception research and the HHS final regulations.
    Dresser RS
    IRB; 1981 Apr; 3(4):3-4. PubMed ID: 11661944
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for research in schizophrenia.: an alternative for special studies.
    Posever TA; Chelmow T
    IRB; 2001; 23(1):10-5. PubMed ID: 12530451
    [No Abstract]   [Full Text] [Related]  

  • 6. The regulation of human experimentation in the United States--a personal odyssey.
    Katz J
    IRB; 1987; 9(1):1-6. PubMed ID: 11649890
    [No Abstract]   [Full Text] [Related]  

  • 7. Current status of research on the federal guidelines for performing research using an exception from informed consent.
    Schmidt TA; Lewis RJ; Richardson LD
    Acad Emerg Med; 2005 Nov; 12(11):1022-6. PubMed ID: 16264068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National commission proposes numerous new regulations of institutional review boards.
    Maloney DM
    Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
    [No Abstract]   [Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsible conduct of radiology research: part II. Regulatory requirements for human research.
    Cooper JA
    Radiology; 2005 Sep; 236(3):748-52. PubMed ID: 16118157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Institutional review board (IRB) violated numerous regulations.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):7-8. PubMed ID: 12530381
    [No Abstract]   [Full Text] [Related]  

  • 12. Children as research subjects: a proposal to revise the current federal regulations using a moral framework.
    Ross LF
    Stanford Law Pol Rev; 1997; 8(1):159-76. PubMed ID: 16528858
    [No Abstract]   [Full Text] [Related]  

  • 13. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 14. Proposed requirements for informed consent go beyond current federal regulations.
    Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
    [No Abstract]   [Full Text] [Related]  

  • 15. Human subject protections in the United States: perspectives from the Office for Protection from Research Risks.
    Russell-Einhorn M; Ellis GB
    J Biolaw Bus; 1998; 1(2):36-8. PubMed ID: 12739540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of altered informed consent in pragmatic clinical research.
    McKinney RE; Beskow LM; Ford DE; Lantos JD; McCall J; Patrick-Lake B; Pletcher MJ; Rath B; Schmidt H; Weinfurt K
    Clin Trials; 2015 Oct; 12(5):494-502. PubMed ID: 26374677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case of two devices: disclosure to subjects following Phase IV ("post-marketing") research.
    Anderson JR; Jameton A; Reitemeier PJ; Prentice E
    IRB; 1995; 17(3):6-9. PubMed ID: 11654269
    [No Abstract]   [Full Text] [Related]  

  • 18. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 19. Has compliance eclipsed ethics? Should we expect serious ethical consideration or give up and admit that regulations are the only hope?
    Dubler N; Barnes M
    Prot Hum Subj; 2005; (12):7-9. PubMed ID: 16317857
    [No Abstract]   [Full Text] [Related]  

  • 20. Federal investigation concludes that institutional review boards are in trouble.
    Maloney DM
    Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.